UK - English
Select a Country

OUR COMMITMENT TO SUSTAINABLE HEALTHCARE

As a new biopharmaceutical company in the 21st century, we have the opportunity to commit to a fundamentally different approach to addressing the healthcare challenges in our society. Breakthrough medicines, devices and medical approaches have dramatically improved the health of the world; people are living longer, healthier lives; but the burden of chronic disease is becoming more costly.

pilot_button
download-report_btn
sh_video_button

PATIENTS AS PARTNERS AWARDS

As part of AbbVie’s flagship Sustainable Healthcare programme, our awards programme recognises, celebrates and spreads examples of innovative practices in healthcare.

There are three categories with a travel or research bursary of up to £3,000 for the winner to use to help take forward the ideas that will make a real difference for patients. The awards are open to all UK patient groups, healthcare professionals and healthcare organisations. The deadline for this years entries is 1st May 2017 and the awards will be made at our third annual Sustainable Healthcare conference at the end of the year.

For more information about the different categories and to download an entry for, please visit our Patients as Partners Awards page.


SUSTAINABLE HEALTHCARE IN ENGLAND

At AbbVie, our vision is to help build a sustainable future for our health system. Life-long prevention, early diagnosis and integrated care of chronic diseases need to be embraced to extend the healthy life years of our aging population and relieve the burden on our health system.

New approaches are required to address the challenges our society faces today. At AbbVie, we have the expertise and commitment to be part of the solution.
Download the Sustainable Healthcare Infographic

Leave the UK site

The Abbvie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The Abbvie Internet site that you have requested may be in a language that differs from your country of origin.

The Abbvie Internet site that you have requested may not be optimised for your screen size.

Do you wish to continue to this Abbvie site?

Exit abbvie.co.uk

The product-specific Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in other countries or regions. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.

The product-specific Internet site that you have requested may not be optimized for your screen size.

Do you wish to continue to this product-specific site?

AXCOR121934c(2) - DECEMBER 2014

Exit abbvie.co.uk

Notice

The “Yes” link below will take you out of AbbVie family of websites

Links which take you out of AbbVie worldwide web sites are not under the control of AbbVie, and AbbVie are not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?